Management of Thrombosis in a Patient with Three Thrombophilic Disorders

References

• Phillippe HM, Hornsby LB, Tredway S, Armstrong EM, Bellone JM. Inherited thrombophilia. J Pharm Pract. 2014;27(3):227–233. doi:10.1177/0897190014530390
   PubMedGoogle Scholar
• Khan F, Tristlcher T, Khan SR, Rodger MA. Venous thromboembolism. Lancet. 2021;398(10294):64–77. doi:10.1016/S0140-6736(20)32658-1
   PubMed Web of Science ®Google Scholar
• Lindhoff-Last E, Luxembourg B. Evidence-based indications for thrombophilia screening. VASA. 2008;37(1):19–30. doi:10.1024/0301-1526.37.1.19
   PubMedGoogle Scholar
• Takagi Y, Kato I, Ando Y, et al. Antithrombin- resistant prothrombin Yukuhashi mutation also causes thrombomodulin resistance in fibrinogen clotting but not in protein C activation. Thromb Res. 2014;134(4):914–917. doi:10.1016/j.thromres.2014.07.040
   PubMed Web of Science ®Google Scholar
• Ammollo CT, Semeraro F, Colucci M, Simioni P. Factor IX Padua enhances the fibrinolytic resistance of plasma clots. Thromb Haemost. 2014;111(2):226–232. doi:10.1160/TH13-06-0489
   PubMed Web of Science ®Google Scholar
• Armstrong EM, Bellone JM, Hornsby LB, Treadway S, Phillippe HM. Acquired thrombophilia. J Pharm Pract. 2014;27(3):234–242. doi:10.1177/0897190014530424
   PubMedGoogle Scholar
• Marco-Rico A, Marco-Vera P. Antithrombin deficiency and thrombosis: a wide clinical scenario in a single institution. J Blood Med. 2023;14(1):499–506. doi:10.2147/JBM.S416355
   PubMedGoogle Scholar
• Croles FN, Borjas-Howard J, Nasserinejad K, Leebeek FW, Meijer K. Risk of venous thrombosis in antithrombin deficiency: a systematic review and Bayesian meta-analysis. Semin Thromb Hemost. 2018;44(4):315–326. doi:10.1055/s-0038-1625983
   PubMed Web of Science ®Google Scholar
• Corral J, de la Morena-Barrio ME, Vicente V. The genetics of antithrombin. Thromb Res. 2018;169:23–29. doi:10.1016/j.thromres.2018.07.008
   PubMed Web of Science ®Google Scholar
• Connors JM. Thrombophilia testing and venous thrombosis. NEJM 2017; 377(12):1177–1187. doi:10.1056/NEJMra1700365
   PubMed Web of Science ®Google Scholar
• Losonczy H, Nagy A, Toth O, et al. Prevalence and clinical significance of single and combined inherited thrombophilias. Blood. 2005;106(11):1632. doi:10.1182/blood.V106.11.1632.1632
   Web of Science ®Google Scholar
• Pabinger I, Vossen CY, Lang J, et al. Mortality and inherited thrombophilia: results from the European prospective cohort on thrombophilia. J Thromb Haemost. 2012;10(2):217–222. doi:10.1111/j.1538-7836.2011.04573.x
   PubMed Web of Science ®Google Scholar
• Marco-Rico A, Marco-Vera P. Thrombotic antiphospholipid síndrome and direct oral anticoagulants: unmet needs and review of the literature. Semin Thromb Hemost. 2023;49(7):736–743. doi:10.1055/s-0043-1767728
   PubMedGoogle Scholar
• Weitz J, Eikelboom JW, Samama MM. New antithrombotic drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. CHEST. 2012;141(Suppl 2):e120S–e141S. doi:10.1378/chest.11-2294
   PubMed Web of Science ®Google Scholar
• Castillo-Pérez M, Jerjes-Sánchez C, Rodríguez D, Paredes-Vázquez JG, Panneflek J, Vázquez-Guajardo M. Clinical outcomes of very elderly patients treated with ultrasound-assisted catheter-directed thrombolysis for pulmonary embolism: a systematic review. J Thromb Thrombolysis. 2021;52(1):260–271. doi:10.1007/s11239-021-02409-3
   PubMed Web of Science ®Google Scholar
• Giri J, Sista AK, Weinberg I, et al. Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence: a scientific statement from the American Heart Association. Circulation. 2019;140(20):e774–e801. doi:10.1161/CIR.0000000000000707
   PubMed Web of Science ®Google Scholar
• Sagris M, Tzoumas A, Kokkinidis DG, Korosoglou G, Lichtenberg M, Tzavellas G. Invasive and pharmacological treatment of deep vein thrombosis: a scoping review. Curr Pharm Des. 2022;28(10):778–786. doi:10.2174/1381612828666220418084339
   PubMed Web of Science ®Google Scholar
• Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315–352. doi:10.1016/j.chest.2015.11.026
   PubMed Web of Science ®Google Scholar
• Watson L, Broderick C, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev. 2016;11(11):CD002783. doi:10.1002/14651858.CD002783.pub4
   PubMedGoogle Scholar
• Enden T, Haig Y, Klow NE, et al.; CaVenT Study Group. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomized controlled trial. Lancet. 2012;379(9810):31–38. doi:10.1016/S0140-6736(11)61753-4
   PubMed Web of Science ®Google Scholar
• Farrokhi M, Khurshid M, Mohammadi S, et al. Comparison of ultrasound-accelerated versus conventional catheter-directed thrombolysis for deep vein thrombosis: a systematic review and meta-analysis. Vascular. 2022;30(2):365–374. doi:10.1177/17085381211010532
   PubMed Web of Science ®Google Scholar
• Weinberg I, Vedantham S, Salter A, et al. ATTRACT Trial Investigators. Relationships between the use of pharmacomechanical catheter-directed thrombolysis, sonographic findings and clinical outcomes in patients with acute proximal DVT: results from the ATTRACT Multicenter Randomized Trial. Vasc Med. 2019;24(5):442–451. doi:10.1177/1358863X19862043
   PubMed Web of Science ®Google Scholar
• Wang CN, Deng HR. Percutaneous endovenous intervention plus anticoagulation versus anticoagulation alone for treating patients with proximal deep vein thrombosis: a meta-analysis and systematic review. Ann Vasc Surg. 2018;49:39–48. doi:10.1016/j.avsg.2017.09.027
   PubMed Web of Science ®Google Scholar
• Dela Morena Barrio ME, López-Gálvez R, Martínez-Martínez I, et al. Defects of splicing in antithrombin deficiency. Res Pract Thromb Haemost. 2017;1(2):216–222. doi:10.1002/rth2.12025
   PubMed Web of Science ®Google Scholar
• Human Gene Mutation Database (HGMD); 2023. Available from: www.hgmd.cf.ac.uk. Accessed August 24, 2023.
   Google Scholar
• Larsen OH, Kjaergaard AD, Hvas AM, Nissen PH. Genetic variants in the protein S (PROS1) gene and protein S deficiency in a Danish population. TH Open. 2021;5(4):479–488. doi:10.1055/s-0041-1736636
   Google Scholar
• Dautaj A, Krasi G, Bushati V, et al. Hereditary thrombophilia. Acta Biomed. 2019;90(10–S):44–46. doi:10.23750/abm.v90i10-S.8758
   PubMedGoogle Scholar
• Harter K, Levine M, Henderson SO. Anticoagulation drug therapy: a review. West J Emerg Med. 2015;16(1):11–17. doi:10.5811/westjem.2014.12.22933
   PubMed Web of Science ®Google Scholar
• Dilektasli AG, Demirdogen Cetinoglu E, Acet NA, et al. Catheter-directed therapy in acute pulmonary embolism with right ventricular dysfunction: a promising modality to provide early hemodynamic recovery. Med Sci Monit. 2016;22:1265–1273. doi:10.12659/MSM.897617
   PubMed Web of Science ®Google Scholar
• Liu G, Zhao Z, Cui C, et al. Endovascular management of extensive lower extremity acute deep vein thrombosis with AngioJet rheolytic thrombectomy plus catheter-directed thrombolysis from contralateral femoral access. Phlebology. 2019;34(4):257–265. doi:10.1177/0268355518790407
   PubMed Web of Science ®Google Scholar
• Khidder L, Gendron N, Mauge L. Inherited thrombophilia in the era of direct oral anticoagulants. Int J Mol Sci. 2022;23(3):1821. doi:10.3390/ijms23031821
   PubMed Web of Science ®Google Scholar